Shenyang Pharmaceutical University, Shenyang 110016, China.
Department of Pharmacy, Hebei North University, Hebei Key Laboratory of Neuropharmacology, Zhangjiakou 075132, China.
Oxid Med Cell Longev. 2023 Jan 17;2023:3310621. doi: 10.1155/2023/3310621. eCollection 2023.
Although accumulated evidence supports the notion that calpain contributes to eye disease, the mechanisms by which calpain promotes RPE injury are not defined. The present study is aimed at investigating whether the effect of NaIO-exos (exosomes derived from RPE cells under NaIO stimulation) on the dysfunction of the autophagy-lysosomal pathway (ALP) and apoptosis is based on its regulation of calpain activation in ARPE-19 cells and rats. The results showed that calpain-2 activation, ALP dysfunction, and apoptosis were induced by NaIO-exos in ARPE-19 cells. NaIO-exo significantly increased autophagic substrates by activating lysosomal dysfunction. ALP dysfunction and apoptosis in vitro could be eliminated by knocking down calpain-2 (si-C2) or the inhibitor calpain-2-IN-1. Further studies indicated that NaIO-exo enhanced calpain-2 expression, ALP dysfunction, apoptosis, and retinal damage in rats. In summary, these results demonstrate for the first time that calpain-2 is one of the key players in the NaIO-exo-mediated ALP dysfunction, apoptosis, and retinal damage and identify calpain-2 as a promising target for therapies aimed at age-related macular degeneration (AMD).
虽然越来越多的证据支持钙蛋白酶参与眼病的观点,但钙蛋白酶促进 RPE 损伤的机制尚未确定。本研究旨在探讨 NaIO-exos(在 NaIO 刺激下 RPE 细胞衍生的外泌体)对自噬溶酶体途径(ALP)功能障碍和细胞凋亡的影响是否基于其对 ARPE-19 细胞和大鼠中钙蛋白酶激活的调节。结果表明,NaIO-exos 在 ARPE-19 细胞中诱导钙蛋白酶-2 激活、ALP 功能障碍和细胞凋亡。NaIO-exo 通过激活溶酶体功能障碍显著增加自噬底物。体外敲低钙蛋白酶-2(si-C2)或抑制剂钙蛋白酶-2-IN-1 可消除 ALP 功能障碍和细胞凋亡。进一步的研究表明,NaIO-exo 增强了大鼠中钙蛋白酶-2 的表达、ALP 功能障碍、细胞凋亡和视网膜损伤。综上所述,这些结果首次表明钙蛋白酶-2 是 NaIO-exo 介导的 ALP 功能障碍、细胞凋亡和视网膜损伤的关键因素之一,并确定钙蛋白酶-2 是治疗年龄相关性黄斑变性(AMD)的有希望的靶点。